Innate Pharma Provides Update on Silicon Valley Bank Exposure Read more about Innate Pharma Provides Update on Silicon Valley Bank Exposure
Press Release: Sanofi to acquire Provention Bio, adding to portfolio TZIELD, the first disease-modifying treatment for the delay of Stage 3 type 1 diabetes (T1D) Read more about Press Release: Sanofi to acquire Provention Bio, adding to portfolio TZIELD, the first disease-modifying treatment for the delay of Stage 3 type 1 diabetes (T1D)
MDxHealth Confirms No Exposure to Silicon Valley Bank or Silvergate Bank Read more about MDxHealth Confirms No Exposure to Silicon Valley Bank or Silvergate Bank
Reach Subsea ASA: Registration of prospectus and launch of subsequent offering Read more about Reach Subsea ASA: Registration of prospectus and launch of subsequent offering
Cool Company Ltd. concludes regulatory review process for NYSE listing and provides update on trading suspension Read more about Cool Company Ltd. concludes regulatory review process for NYSE listing and provides update on trading suspension